American Psychiatric Association (2010) (eds: Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS). Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 3rd Edition.
Fitzgerald PB, Hoy K, McQueen S, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsycholpharmacology. 2009;34(5):1255-1262.
Gaynes BN, et. al. Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. Comparative Effectiveness Review No. 33. AHRQ Publication No. 11-EHC056-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2011. Available at: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder. A shamcontrolled randomized trial. Arch Gen Psychiatry. 2010;60(5)507-516.
George MS. Transcranial magnetic stimulation for the treatment of depression. Expert Rev. Neurother 2010;10(11):1761-1772. Glenberg AJ, Freeman MP, Markowitz JC, et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. American Psychiatric Association October 2010.
http://www.psychiatryonline.com/pracGuide/PracticePDFs/PG_Depression3rdEd.pdf Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-73.
Hayes Inc. Evaluating the efficacy of transcranial magnetic stimulation to treat major depression. Hayes Overview. Lansdale, PA; Hayes, May 25, 2010.
Herbsman T, Avery D. Ramsey D, et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry. 2009;66(5):509-515.
Holtzheimer PE, McDonald WM, Mutfi M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety 2010;27:960-963.
Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34:522-534.
Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008;11(1):131-147.
Mark DH, Aronson N, Ziegler KM, et al. Transcranial Magnetic Stimulation for Depression. TEC Assessment Program October 2009;24(5).
Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480-491.
O'Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216.
Rosenberg O, Zangen A, Stryjer R, et al. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimulation 2010; 3:211-217.
Rush AJ, Trivedi MY, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-1917.
Schutter DJ. Antidepressant efficacy of high frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham controlled designs: a meta-analysis. Psychol Med. 2009;39:65-75.
The Regance Group. Medical Policy -Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders. Policy No. 17. Updated 03/01/2011.
Uwe H, Padberg F, Unger J, Spitzer M, and Schonfeldt-Lecuona S. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 20001;50:58-61.
UnitedHealthCare Medical Policy 2011T0536B effective January 1, 2011. Transcranial Magnetic Stimulation. https://www.unitedhealthcareonline.com. Accessed 04/28/2011. U.S. Food and Drug Administration (2007) Neurological Devices Panel of the Medical Devices Advisory Committee. January 26, 2007.